Rafarma Pharmaceuticals Statistics
Total Valuation
RAFA has a market cap or net worth of 6.06 million.
| Market Cap | 6.06M |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
RAFA has 87.77 million shares outstanding.
| Current Share Class | 87.77M |
| Shares Outstanding | 87.77M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 45.49 |
| PB Ratio | 0.02 |
| P/TBV Ratio | 0.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 242.59 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.19 |
Financial Efficiency
Return on equity (ROE) is -0.07% and return on invested capital (ROIC) is -0.04%.
| Return on Equity (ROE) | -0.07% |
| Return on Assets (ROA) | -0.04% |
| Return on Invested Capital (ROIC) | -0.04% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 7.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.00 |
| Inventory Turnover | 0.64 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.99% in the last 52 weeks. The beta is 0.54, so RAFA's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | -50.99% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.07 |
| Relative Strength Index (RSI) | 52.32 |
| Average Volume (20 Days) | 24,601 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.32 |
Income Statement
In the last 12 months, RAFA had revenue of 133,333 and -117,223 in losses. Loss per share was -0.01.
| Revenue | 133,333 |
| Gross Profit | n/a |
| Operating Income | -108,333 |
| Pretax Income | -117,223 |
| Net Income | -117,223 |
| EBITDA | n/a |
| EBIT | -108,333 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 116,854 in cash and 240,036 in debt, with a net cash position of -123,182 or -0.00 per share.
| Cash & Cash Equivalents | 116,854 |
| Total Debt | 240,036 |
| Net Cash | -123,182 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 329.75M |
| Book Value Per Share | 40.49 |
| Working Capital | 257,254 |
Cash Flow
| Operating Cash Flow | 25,000 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -81.25% |
| Pretax Margin | -87.92% |
| Profit Margin | -87.92% |
| EBITDA Margin | n/a |
| EBIT Margin | -81.25% |
| FCF Margin | n/a |
Dividends & Yields
RAFA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -1.93% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 20, 2012. It was a reverse split with a ratio of 0.1.
| Last Split Date | Nov 20, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | 0 |
| Piotroski F-Score | 2 |